Home » Newsletters » BioWorld Science

BioWorld Science

July 20, 2005

View Archived Issues

Drug discovery targets for atherosclerosis

BPC-157 enhances healing during CO2 laser therapy

ADHD treatment consistency varies with methylphenidate formulations

Candesartan reduces new-onset diabetes in heart failure patients

Transdermal 4-hydroxytamoxifen demonstrates activity in breast cancer patients

Adenoviral interferon beta delivery feasible for pleural malignancies

Gene therapy with IL-10 ameliorates atherogenesis in mice

PPARalpha/delta agonists show beneficial effects on HDL-C in primates

Purdue Pharma suspends Palladone Capsules

Ortec to begin confirmatory OrCel trial

Updated labeling for Cialis, Levitra and Viagra

Brazilian patients receive Zilver PTX paclitaxel-coated stent for PAD

Xoma to terminate BPI agreement with Zephyr Sciences

Approvable letter for Pulminiq

Adherex enters into licensing deal with GlaxoSmithKline

ChemGenex plans registration-directed trials for Ceflatonin

Genaissance enters into HAP Technology agreement with Organon

Nautilus advances improved IFN-beta into preclinical development

MacroGenics signs agreement for anti-CD3 antibody for type 1 diabetes

Active Biotech's 57-57 successfully completes first clinical study

Antitumor efficacy reported for yttrium-90 microspheres

Sankyo to resume development of CS-917

Good safety and pharmacokinetic profile of XP-19986 in healthy volunteers

Rexin-G enters phase I study for pancreatic cancer

Recent patents describe novel antibacterial agents

LG Life Sciences claims new agents for acute hepatitis, liver cirrhosis and rheumatoid arthritis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...